Rabab S. Hamad

616 total citations
52 papers, 357 citations indexed

About

Rabab S. Hamad is a scholar working on Molecular Biology, Epidemiology and Nutrition and Dietetics. According to data from OpenAlex, Rabab S. Hamad has authored 52 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Nutrition and Dietetics. Recurrent topics in Rabab S. Hamad's work include Sirtuins and Resveratrol in Medicine (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Parasites and Host Interactions (4 papers). Rabab S. Hamad is often cited by papers focused on Sirtuins and Resveratrol in Medicine (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Parasites and Host Interactions (4 papers). Rabab S. Hamad collaborates with scholars based in Egypt, Saudi Arabia and Romania. Rabab S. Hamad's co-authors include Sameh Saber, Elsayed A. Elmorsy, Mustafa Ahmed Abdel‐Reheim, Attalla F. El‐kott, Hayder M. Al‐kuraishy, Mahmoud E. Youssef, Kareem Morsy, Mohammed A. AlShehri, Simona Cavalu and Gaber El‐Saber Batiha and has published in prestigious journals such as PLoS ONE, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Rabab S. Hamad

44 papers receiving 353 citations

Peers

Rabab S. Hamad
Comparison fields: 5 of 90
  • Molecular Biology 120
  • Cancer Research 44
  • Physiology 38
  • Epidemiology 36
  • Oncology 33
Nicoleta Andreescu Romania
Chunlan Yang China
Shuping Zhong China
Wen‐Li Hsu Taiwan
Wang-xian Tang China
Asmaa Mohammed ShamsEldeen Egypt
Gaber El-Saber Batiha Egypt
Tatiana Bandaletova United Kingdom
Xiaohan Li China
Yen-Chang Chen Taiwan
Nicoleta Andreescu Romania View profile →
Citations per field, relative to Rabab S. Hamad
Rabab S. Hamad · 1×
Citations per year, relative to Rabab S. Hamad
Rabab S. Hamad · 1×

Countries citing papers authored by Rabab S. Hamad

Since Specialization
Citations

This map shows the geographic impact of Rabab S. Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabab S. Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabab S. Hamad more than expected).

Fields of papers citing papers by Rabab S. Hamad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabab S. Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabab S. Hamad. The network helps show where Rabab S. Hamad may publish in the future.

Co-authorship network of co-authors of Rabab S. Hamad

This figure shows the co-authorship network connecting the top 25 collaborators of Rabab S. Hamad. A scholar is included among the top collaborators of Rabab S. Hamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabab S. Hamad. Rabab S. Hamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Sirtuin 6-driven ASC deacetylation confers hepatoprotection: A promising approach to inflammasome inhibition in experimental NASH European Journal of Pharmacology Rabab S. Hamad, Elsayed A. Elmorsy et al. 1
2 Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitis European Journal of Pharmaceutical Sciences Sameh Saber, Zubida M. Al‐Majdoub et al. 3
3 Dual-sensitive gelatin-coated chitosan microparticles for targeted semaglutide pulmonary delivery: a novel approach to enhancing anti-inflammatory and anti-fibrotic effects International Immunopharmacology Rabab S. Hamad, Sameh Saber et al. 0
4 Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6 European Journal of Pharmaceutical Sciences Elsayed A. Elmorsy, Manal Mohamed Kamal et al. 0
5 Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions International Journal of Nanomedicine Simona Cavalu, Rabab S. Hamad et al. 7
6 Phage therapy and its role in cancer treatment and control Folia Microbiologica Ahmed S. Doghish, Mahmoud A. Elrebehy et al. 1
7 AGK2 and nicotinamide riboside reveal SIRT2's protective role in a diabetic–dietary rat model of NASH via deacetylation of NLRP3, LKB1, and FOXO3a and restoration of AMPK–ACC/PGC-1α–Nrf2 signaling International Immunopharmacology Rabab S. Hamad, Elsayed A. Elmorsy et al. 1
8 STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide Frontiers in Pharmacology A. M. Abdelhamid, Sameh Saber et al. 4
9 Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib) Life Sciences Elsayed A. Elmorsy, Sameh Saber et al. 7
10 Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NFκB/NLRP3/IL-1β signaling in rats: Unraveling new roles beyond calcium channel blocking International Immunopharmacology Elsayed A. Elmorsy, Rabab S. Hamad et al. 6
11 Diagnosis Dilemma of Fibroblastic Osteosarcoma: A Case Report Cureus Rabab S. Hamad et al. 1
12 Linagliptin, a DPP ‐4 inhibitor, activates AMPK / FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights The FASEB Journal Osama A. Mohammed, Ahmed S. Doghish et al. 5
13 Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies European Journal of Pharmaceutical Sciences Elsayed A. Elmorsy, Sameh Saber et al. 40
14 PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond Frontiers in Pharmacology Sameh Saber, Elsayed A. Elmorsy et al. 3
15 Orexins in apoptosis: a dual regulatory role Frontiers in Cellular Neuroscience Simona Cavalu, Sameh Saber et al. 3
16 Role of brain renin–angiotensin system in depression: A new perspective CNS Neuroscience & Therapeutics Naif H. Ali, Hayder M. Al‐kuraishy et al. 27
17 The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review Journal of Immunology Research Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb et al. 4
18 SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway Cell Stress and Chaperones Rabab S. Hamad, Hayder M. Al‐kuraishy et al. 13
19 Rutin, a Flavonoid Compound Derived from Garlic, as a Potential Immunomodulatory and Anti-Inflammatory Agent against Murine Schistosomiasis mansoni Nutrients Rabab S. Hamad 13
20 Advantages of bioconjugated silica-coated nanoparticles as an innovative diagnosis for human toxoplasmosis Acta Tropica Rabab S. Hamad et al. 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026